como funciona glp 1 SOCHOB Qué hace un GLP-1 y

While some clinical investigations indicate that combination therapy primarily exhibits gastrointestinal-related adverse effects without significant escalation in overall adverse event incidence 14,15 , contrasting expert opinions advocate for metformin dose reduction or discontinuation during GLP-1 receptor agonist treatment 16

Patients should be counselled on strategies to minimise gastrointestinal symptoms, such as eating smaller meals, avoiding high-fat foods, and staying well-hydrated

Some wont yet the research is moving faster than the textbooks

Related Articles:

Similarly, there was no significant difference in PsA risk between GLP-1 RA and DPP-4i users (HR: 0.890